AMPK has classically been viewed as an enzyme that senses when a cell is energy-deficient and then assists it in restoring ATP levels. During the preceding grant period we obtained data that have led us to suggest that (1) AMPK can function as a coordinator of cellular fuel metabolism in tissues in which energy deficiency may not be an obvious factor and (2) that in these situations, AMPK may be up- or down- regulated by nutrients and hormones. To test these hypotheses, studies will be carried out with the following aims: (1) To examine the biochemical and morphological basis for the decrease in AMPK activity caused by a glucose surfeit. Using isolated Hep G2 cells, incubated rat muscle, and rat liver in vivo as models, we will utilize biochemical and immunoelectron microscopic approaches to examine whether observed decreases in AMPK activity are caused by changes in AMPK binding to glycogen, an altered redox state, or decreased activity of an AMPK-kinase. We will also determine whether glucagon, which has been reported to activate AMPK in liver, prevents this from occurring. (2) To examine how IL-6 and catecholamines, both of which are increased by exercise, activate AMPK in muscle and adipose tissue. We will also test the hypothesis that AMPK activation protects the adipocyte against lipotoxicity when a high rate of lipolysis increases intracellular FFA levels. (3) To characterize malonyl CoA decarboxylase (MCD), an enzyme that we have recently identified as an AMPK target. We have found three MCD isoforms in liver and muscle and will attempt to determine whether they result from differential processing and/or phosphorylation. We will also examine whether AMPK activation in vitro changes the distribution of these isoforms and whether similar changes occur in vivo when AMPK activity is altered. Finally, we will attempt to identify key phosphorylation sites that modify MCD activity and generate antibodies to the phosphoenzyme. These studies will provide novel information about the regulation of the AMPK and malonyl CoA by nutrients and hormones. They are relevant to public health, since dysregulation of the AMPK and malonyl CoA network has been linked to the pathogenesis of the metabolic syndrome and may be a target for its treatment and prevention.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK019514-30
Application #
7743086
Study Section
Cellular Aspects of Diabetes and Obesity Study Section (CADO)
Program Officer
Laughlin, Maren R
Project Start
1979-06-01
Project End
2011-06-16
Budget Start
2009-12-01
Budget End
2011-06-16
Support Year
30
Fiscal Year
2010
Total Cost
$298,692
Indirect Cost
Name
Boston Medical Center
Department
Type
DUNS #
005492160
City
Boston
State
MA
Country
United States
Zip Code
02118
Weikel, Karen A; Ruderman, Neil B; Cacicedo, José M (2016) Unraveling the actions of AMP-activated protein kinase in metabolic diseases: Systemic to molecular insights. Metabolism 65:634-45
Mugabo, Yves; Zhao, Shangang; Seifried, Annegrit et al. (2016) Identification of a mammalian glycerol-3-phosphate phosphatase: Role in metabolism and signaling in pancreatic ?-cells and hepatocytes. Proc Natl Acad Sci U S A 113:E430-9
Pepin, Émilie; Al-Mass, Anfal; Attané, Camille et al. (2016) Pancreatic ?-Cell Dysfunction in Diet-Induced Obese Mice: Roles of AMP-Kinase, Protein Kinase C?, Mitochondrial and Cholesterol Metabolism, and Alterations in Gene Expression. PLoS One 11:e0153017
Weikel, Karen A; Cacicedo, José M; Ruderman, Neil B et al. (2016) Knockdown of GSK3? increases basal autophagy and AMPK signalling in nutrient-laden human aortic endothelial cells. Biosci Rep 36:
Coughlan, Kimberly A; Valentine, Rudy J; Sudit, Bella S et al. (2016) PKD1 Inhibits AMPK?2 through Phosphorylation of Serine 491 and Impairs Insulin Signaling in Skeletal Muscle Cells. J Biol Chem 291:5664-75
Xu, X Julia; Apovian, Caroline; Hess, Donald et al. (2015) Improved Insulin Sensitivity 3 Months After RYGB Surgery Is Associated With Increased Subcutaneous Adipose Tissue AMPK Activity and Decreased Oxidative Stress. Diabetes 64:3155-9
Nolan, Christopher J; Ruderman, Neil B; Kahn, Steven E et al. (2015) Insulin resistance as a physiological defense against metabolic stress: implications for the management of subsets of type 2 diabetes. Diabetes 64:673-86
Coughlan, Kimberly A; Balon, Thomas W; Valentine, Rudy J et al. (2015) Nutrient Excess and AMPK Downregulation in Incubated Skeletal Muscle and Muscle of Glucose Infused Rats. PLoS One 10:e0127388
Doménech, Elena; Maestre, Carolina; Esteban-Martínez, Lorena et al. (2015) AMPK and PFKFB3 mediate glycolysis and survival in response to mitophagy during mitotic arrest. Nat Cell Biol 17:1304-16
Martínez de Morentin, Pablo B; Lage, Ricardo; González-García, Ismael et al. (2015) Pregnancy induces resistance to the anorectic effect of hypothalamic malonyl-CoA and the thermogenic effect of hypothalamic AMPK inhibition in female rats. Endocrinology 156:947-60

Showing the most recent 10 out of 91 publications